KYORIN Holdings, Incorporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares KYORIN Holdings, Incorporation with three other
companies in this sector in Japan:
Kaken Pharmaceutical Co Ltd
sales of 101.48 billion Japanese Yen [US$942.74 million]
of which 98%
Nippon Shinyaku Co Ltd
(98.78 billion Japanese Yen [US$917.68 million]
of which 86%
was Pharmaceutical Products), and
Tsumura & Co
(114.95 billion Japanese Yen [US$1.07 billion]
of which 100%
was Pharmaceutical Items).
KYORIN Holdings, Incorporation reported sales of ¥115.37 billion (US$1.07 billion)
March of 2017.
decrease of 3.4%
versus 2016, when the company's sales were ¥119.48 billion.
Contributing to the drop in overall sales was the 7.3% decline
in Pharmaceutical Business, from ¥118.24 billion to ¥109.57 billion.
However, these declines were partially offset by the increase in sales of
Healthcare Business (up 366.8% to ¥5.81 billion)